Global Interventional Pulmonology Market: Size, Trends & Forecast with Impact Analysis of COVID-19 (2021-2025)

The report titled “Global interventional pulmonology Market: Size, Trends & Forecast with Impact Analysis of COVID-19 (2021-2025)”, provides an in depth analysis of the global interventional pulmonology market by value, by product type, by bronchoscopy examination procedures, by region, etc. The report provides a regional analysis of the bronchoscopy examination procedures, including the following regions: China, Europe, The US, and ROW. The report also provides a detailed analysis of the COVID-19 impact on the global interventional pulmonology market.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the global interventional pulmonology market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The global interventional pulmonology market is fragmented with the presence of many major players. The key players of the market: Medtronic Plc, Boston Scientific Corporation, Olympus Corporation, and Body Vision Medical are also profiled with their financial information and respective business strategies.

Country Coverage

China
Europe
The US
ROW

Company Coverage

Medtronic Plc
Boston Scientific Corporation
Olympus Corporation
Body Vision Medical

Executive Summary

Pollution is not only harming the beautiful environment; it also leads to the various chronic diseases that are affecting the lives of individuals who live on this planet. Chronic respiratory illnesses are among the most common non-communicable diseases worldwide due to the smoking and presence of radon and other harmful substances in the atmosphere. The most common chronic respiratory diseases are COPD and asthma.

Pulmonary diseases are the leading cause of death and disability worldwide. Pulmonology is a medical specialty that focuses on respiratory and breathing problems. Interventional pulmonology is a relatively new discipline in the realm of pulmonary medicine. In interventional pulmonology, endoscopy and other technologies are used to diagnose and treat diseases in the lungs and chest.

The most common pulmonary diseases are common obstructive pulmonary diseases (COPD), asthma, emphysema, lung cancer, pneumonia, pleural effusion, and chronic bronchitis. There are the two types of interventional pulmonology diagnostic methods: bronchoscopy and percutaneous diagnostic procedures. The interventional pulmonology market is divided into three segments: by product type, by indication, and by end user.

The global interventional pulmonology market is projected to rise considerably in the next four years i.e. 2021-2025. The global interventional pulmonology market is expected to rise due to rising prevalence of pulmonary diseases, rapid urbanization, increasing old age population, increase in healthcare expenditure, poor atmospheric conditions, favorable government support, and increasing public awareness. The market also faces some challenges like associated risks with interventional pulmonology, and high costs involved.